Dr. Harrison plans to stay in the role of CEO throughout his treatment and will return to the office in 2020.
“Cancer is never good news, of course, but I have every reason to hope for a successful outcome,” Dr. Harrison said in an emailed statement. “I am proud and grateful that my care will be provided by Intermountain caregivers — the best in the land. I look forward to their care and support as I continue to serve our communities as CEO of Intermountain.”
Multiple myeloma is a rare form of cancer in which cancerous plasma cells accumulate in bone marrow. It does not have a cure, but can be managed as a chronic disease, Dr. Harrison noted.
More executive moves:
22 recent hospital, health system executive movesa
IU Health White Memorial Hospital taps Renea Smith as CNO
Sean Lemon named VP of ancillary services for Texas Health Huguley Hospital
